We found that the XRCC1 mRNA/ALDH2 mRNA ratio is significantly better at predicting the 5-year overall survival rate for both lung (Fig. 7A, compare to 3C) and liver (Fig. 7B, compare to 4C) cancers than ALDH2 levels alone. The gene discussed is ALDH2; the disease is cancer.